한글목차

의약품용 천연 전분 시장 규모는 최근 현저한 성장을 이루고 있습니다. 2025년 61억 1,000만 달러에서 2026년에는 66억 4,000만 달러에 이르고, CAGR 8.6%로 성장할 전망입니다. 지난 몇 년간의 성장은 천연 전분 원료의 가용성, 제네릭 의약품의 확대, 정제 및 캡슐제의 보급, 의약품 제조에 대한 비용 인식 증가, 천연 전분의 규제적 수용성 등에 기인하는 것으로 보입니다.

의약품용 천연 전분 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 2030년에는 92억 3,000만 달러에 이르고, CAGR은 8.6%를 나타낼 전망입니다. 예측 기간 동안의 성장에는 클린 라벨 제제 증가, 지속가능성 요구 사항 증가, 신흥 시장에서의 의약품 제조 확대, 생분해성 첨가제에 대한 수요 증가, 전분 가공 기술의 발전 등이 요인으로 작용할 것으로 예측됩니다. 예측 기간의 주요 동향으로는 천연 유래 및 클린 라벨 첨가제에 대한 수요 증가, 경구용 고체 제형 사용 증가, 결합제 및 붕괴제로서의 채용 확대, 식물 유래 의약품 원료의 확대, 비용 효율적인 첨가제에 대한 관심 증가 등을 들 수 있습니다.

향후 몇 년 동안 만성 질환의 유병률 증가가 의약품용 천연 전분 시장의 성장을 견인할 것으로 예측됩니다. 만성질환은 보통 천천히 진행되어 1년 이상 지속되는 장기적인 병태를 말합니다. 이러한 증가는 주로 고령화에 기인하며, 고령자는 당뇨병, 심혈관 질환, 관절염, 암 등 나이가 들수록 발병 위험이 높아지는 장기적인 건강 문제를 겪기 쉽기 때문입니다. 의약품용 천연전분은 약물의 제제 안정성 향상, 생체이용률 향상, 서방형 실현, 환자의 복약 순응도 증진을 통해 만성질환 관리를 돕습니다. 이를 통해 궁극적으로 이러한 질환의 효과적인 치료와 장기적인 관리를 강화할 수 있습니다. 예를 들어, 2025년 4월 미국 연방 공중보건기관인 질병통제예방센터(CDC) 자료에 따르면, 2023년 기준 미국 성인의 76.4%(약 1억 9,400만 명)가 1개 이상의 만성질환을 앓고 있으며, 젊은 성인의 유병률은 59.5%, 중장년층은 78.4%, 노년층은 93.0%에 이릅니다.%에 이르렀습니다. 그 결과, 만성질환의 유병률 증가가 의약품용 천연 전분 시장의 성장에 기여하고 있습니다.

향후 몇 년 동안 제네릭 의약품 제조의 성장이 의약품용 천연 전분 시장의 성장을 견인할 것으로 예측됩니다. 제네릭 의약품 제조는 특허가 만료된 의약품으로 브랜드 의약품과 생물학적 동등성을 가진 의약품을 제조하는 것을 말합니다. 이 분야는 승인을 가속화하고 더 많은 기업이 브랜드 의약품을 대체할 수 있는 저렴한 대안을 생산하도록 장려하는 규제 지원 증가로 인해 확대되고 있습니다. 제네릭 의약품 제조의 확대는 신뢰할 수 있고 비용 효율적인 첨가제에 대한 수요를 증가시킴으로써 의약품용 천연 전분을 뒷받침하고 있습니다. 이러한 첨가제는 대량 생산되는 다양한 제네릭 제품에서 정제의 제형, 안정성, 약물 전달 효율을 향상시킵니다. 예를 들어, 2024년 11월 미국 식품의약국(FDA)이 발표한 데이터에 따르면, 2023 회계연도에 FDA가 승인한 간소화된 신약 신청(ANDA)은 782건으로 2022 회계연도 722건보다 증가했습니다. 그 결과, 제네릭 의약품 제조의 확대가 의약품용 천연전분 시장의 성장에 기여하고 있음을 알 수 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병(M&A)

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Pharmaceutical native starch is unmodified starch obtained from natural sources such as corn, potato, wheat, or tapioca and used as an excipient in drug formulations. It serves as a binder, disintegrant, or filler in tablets and capsules, helping regulate medication release, enhance stability, and maintain proper tablet formation without undergoing chemical or physical modification.

The main types of pharmaceutical native starches include potato starch, corn starch, and others. Potato starch, a fine white powder extracted from potato tubers, is valued for its smooth texture and excellent binding properties, making it suitable for tablet formulations in pharmaceuticals. It is available in various dosage forms, including oral solids, liquids, topical formulations, injectables, and controlled-release forms. Its functionalities include acting as a texturizing agent, moisture-retention agent, bulking agent, emulsifier, and film-forming agent. It is applied in roles such as binders, coating agents, disintegrants, fillers and extenders, stabilizers, and thickeners, serving end users such as pharmaceutical manufacturers, contract research organizations (CROs), contract manufacturing organizations (CMOs), R&D laboratories, academic institutions, and others.

Tariffs have impacted the pharmaceutical native starch market by increasing the cost of imported starch raw materials and processing inputs used in excipient manufacturing. These effects are most visible across excipient supply chains in Asia Pacific and Europe, where pharmaceutical production depends on consistent raw material quality. Rising tariff related expenses have increased formulation costs and placed pressure on excipient pricing. This has influenced procurement decisions for pharmaceutical manufacturers and contract formulators. However, tariffs have encouraged local agricultural sourcing, expanded regional excipient manufacturing, and strengthened long term supply chain resilience.

The pharmaceuticals native starch market research report is one of a series of new reports from The Business Research Company that provides pharmaceuticals native starch market statistics, including pharmaceuticals native starch industry global market size, regional shares, competitors with a pharmaceuticals native starch market share, detailed pharmaceuticals native starch market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceuticals native starch industry. This pharmaceuticals native starch market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharmaceuticals native starch market size has grown strongly in recent years. It will grow from $6.11 billion in 2025 to $6.64 billion in 2026 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to availability of natural starch sources, expansion of generic pharmaceuticals, widespread use of tablets and capsules, cost sensitivity in drug formulation, regulatory acceptance of native starch.

The pharmaceuticals native starch market size is expected to see strong growth in the next few years. It will grow to $9.23 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to growth in clean-label drug formulations, increasing sustainability requirements, expansion of pharmaceutical manufacturing in emerging markets, rising demand for biodegradable excipients, advancements in starch processing. Major trends in the forecast period include growing demand for natural and clean-label excipients, increasing use in solid oral dosage forms, rising adoption as binder and disintegrant, expansion of plant-based pharmaceutical ingredients, increasing focus on cost-effective excipients.

The rising prevalence of chronic diseases is expected to drive the growth of the pharmaceuticals native starch market in the coming years. Chronic diseases are long-term medical conditions that typically progress slowly and last for a year or more. This increase is largely due to the aging population, as older individuals are more prone to long-term health issues such as diabetes, cardiovascular diseases, arthritis, and cancer, which become more common with age. Pharmaceuticals native starch supports the management of chronic diseases by improving drug formulation stability, enhancing bioavailability, enabling controlled drug release, promoting patient compliance, and ultimately strengthening the effectiveness and long-term management of these conditions. For example, in April 2025, data from the Centers for Disease Control and Prevention, a US-based federal public health agency, reported that 76.4% of U.S. adults-approximately 194 million people-had one or more chronic conditions in 2023, with prevalence rates of 59.5% among young adults, 78.4% among midlife adults, and 93.0% among older adults. Consequently, the increasing prevalence of chronic diseases is contributing to the growth of the pharmaceuticals native starch market.

The growth of generic drug manufacturing is expected to drive the expansion of the pharmaceuticals native starch market in the coming years. Generic drug manufacturing involves producing off-patent medications that are bioequivalent to branded drugs. This sector is expanding due to increasing regulatory support, which accelerates approvals and encourages more companies to produce affordable alternatives to branded medicines. The expansion of generic drug manufacturing supports pharmaceuticals native starch by creating higher demand for reliable, cost-effective excipients that improve tablet formulation, stability, and drug delivery efficiency across a wide range of high-volume generic products. For example, in November 2024, data from the Food and Drug Administration (FDA), a US-based federal agency, reported that in FY 2023, the FDA approved 782 Abbreviated New Drug Applications (ANDAs), up from 722 approvals in FY 2022. Consequently, the expansion of generic drug manufacturing is contributing to the growth of the pharmaceuticals native starch market.

Major companies operating in the pharmaceuticals native starch market are focusing on developing innovative products, such as plant-based textures, to improve drug formulation and enhance patient compliance. Plant-based textures refer to physical properties derived from plant ingredients, such as thickness and gel strength, which help pharmaceuticals utilize native starch by improving tablet binding, disintegration, and mouthfeel, resulting in more natural and effective drug formulations. For example, in February 2024, Ingredion Incorporated, a US-based food company, introduced Novation Indulge 2940 starch, a clean-label texturizer designed to enhance texture and stability in both dairy and alternative dairy products. This innovative pharmaceutical native starch provides functional properties that support improved drug formulation performance, bioavailability, and controlled release while promoting the development of clean-label, sustainable products. Novation Indulge 2940 starch is a versatile ingredient that enhances texture, stability, and consumer acceptance using natural, clean-label components.

Major companies operating in the pharmaceuticals native starch market are Cargill Incorporated, Archer Daniels Midland Company, Ingredion Incorporated, Roquette Freres SA, Emsland Group, Tereos SCA, AGRANA Beteiligungs-AG, Grain Processing Corporation, Universal Starch-Chem Allied Ltd., SPAC Starch Products (India) Private Limited, Sanstar Biopolymers Ltd., Gulshan Polyols Ltd., Tate & Lyle Public Limited Company, BENEO GmbH, Hungrana Kft., Bluecraft Agro Pvt. Ltd., Visco Starch, Manildra Group, Shandong Liujia Pharmaceutical Excipient Co. Ltd., Zhucheng Xingmao Corn Developing Co. Ltd.

North America was the largest region in the pharmaceuticals native starch market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceuticals native starch market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharmaceuticals native starch market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmaceuticals native starch market consists of sales of sorghum starch, barley starch, sweet potato starch, and arrowroot starch. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceuticals Native Starch Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses pharmaceuticals native starch market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceuticals native starch ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pharmaceuticals native starch market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Potato Starch; Corn Starch; Other Types
• 2) By Formulation Type: Oral Solid Dosage Forms; Liquid Dosage Forms; Topical Formulations; Injectable Drugs; Controlled Release Formulations
• 3) By Functionality: Texturizing Agent; Moisture Retention Agent; Bulking Agent; Emulsifying Agent; Film-Forming Agent
• 4) By Application: Binders And Coating Agents; Disintegrants; Fillers And Extenders; Stabilizers; Thickening Agents
• 5) By End-User: Pharmaceutical Manufacturers; Contract Research Organizations (CROs); Contract Manufacturing Organizations (CMOs); Research And Development Labs; Academic Institutions; Other End-users
• Subsegments:
• 1) By Potato Starch: Native Potato Starch (Pharmaceutical Grade); Low Moisture Native Potato Starch; Fine Particle Size Native Potato Starch; High Purity Native Potato Starch
• 2) By Corn Starch: Native Corn Starch (Pharmaceutical Grade); Low Moisture Native Corn Starch; Fine Particle Size Native Corn Starch; High Purity Native Corn Starch
• 3) By Other Types: Rice Starch; Wheat Starch; Tapioca Starch
• Companies Mentioned: Cargill Incorporated; Archer Daniels Midland Company; Ingredion Incorporated; Roquette Freres SA; Emsland Group; Tereos SCA; AGRANA Beteiligungs-AG; Grain Processing Corporation; Universal Starch-Chem Allied Ltd.; SPAC Starch Products (India) Private Limited; Sanstar Biopolymers Ltd.; Gulshan Polyols Ltd.; Tate & Lyle Public Limited Company; BENEO GmbH; Hungrana Kft.; Bluecraft Agro Pvt. Ltd.; Visco Starch; Manildra Group; Shandong Liujia Pharmaceutical Excipient Co. Ltd.; Zhucheng Xingmao Corn Developing Co. Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Pharmaceuticals Native Starch Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Pharmaceuticals Native Starch Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Pharmaceuticals Native Starch Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Pharmaceuticals Native Starch Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Sustainability, Climate Tech & Circular Economy
  • 4.1.2 Industry 4.0 & Intelligent Manufacturing
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Biotechnology, Genomics & Precision Medicine
  • 4.1.5 Artificial Intelligence & Autonomous Intelligence
• 4.2. Major Trends
  • 4.2.1 Growing Demand For Natural And Clean-Label Excipients
  • 4.2.2 Increasing Use In Solid Oral Dosage Forms
  • 4.2.3 Rising Adoption As Binder And Disintegrant
  • 4.2.4 Expansion Of Plant-Based Pharmaceutical Ingredients
  • 4.2.5 Increasing Focus On Cost-Effective Excipients

5. Pharmaceuticals Native Starch Market Analysis Of End Use Industries

• 5.1 Pharmaceutical Manufacturers
• 5.2 Contract Manufacturing Organizations
• 5.3 Research And Development Laboratories
• 5.4 Academic Institutions
• 5.5 Nutraceutical Producers

6. Pharmaceuticals Native Starch Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Pharmaceuticals Native Starch Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Pharmaceuticals Native Starch PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Pharmaceuticals Native Starch Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Pharmaceuticals Native Starch Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Pharmaceuticals Native Starch Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Pharmaceuticals Native Starch Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Pharmaceuticals Native Starch Market Segmentation

• 9.1. Global Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Potato Starch, Corn Starch, Other Types
• 9.2. Global Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oral Solid Dosage Forms, Liquid Dosage Forms, Topical Formulations, Injectable Drugs, Controlled Release Formulations
• 9.3. Global Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Texturizing Agent, Moisture Retention Agent, Bulking Agent, Emulsifying Agent, Film-Forming Agent
• 9.4. Global Pharmaceuticals Native Starch Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Binders And Coating Agents, Disintegrants, Fillers And Extenders, Stabilizers, Thickening Agents
• 9.5. Global Pharmaceuticals Native Starch Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Pharmaceutical Manufacturers, Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs), Research And Development Labs, Academic Institutions, Other End-users
• 9.6. Global Pharmaceuticals Native Starch Market, Sub-Segmentation Of Potato Starch, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Native Potato Starch (Pharmaceutical Grade), Low Moisture Native Potato Starch, Fine Particle Size Native Potato Starch, High Purity Native Potato Starch
• 9.7. Global Pharmaceuticals Native Starch Market, Sub-Segmentation Of Corn Starch, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Native Corn Starch (Pharmaceutical Grade), Low Moisture Native Corn Starch, Fine Particle Size Native Corn Starch, High Purity Native Corn Starch
• 9.8. Global Pharmaceuticals Native Starch Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Rice Starch, Wheat Starch, Tapioca Starch

10. Pharmaceuticals Native Starch Market Regional And Country Analysis

• 10.1. Global Pharmaceuticals Native Starch Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Pharmaceuticals Native Starch Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Pharmaceuticals Native Starch Market

• 11.1. Asia-Pacific Pharmaceuticals Native Starch Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Pharmaceuticals Native Starch Market

• 12.1. China Pharmaceuticals Native Starch Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Pharmaceuticals Native Starch Market

• 13.1. India Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Pharmaceuticals Native Starch Market

• 14.1. Japan Pharmaceuticals Native Starch Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Pharmaceuticals Native Starch Market

• 15.1. Australia Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Pharmaceuticals Native Starch Market

• 16.1. Indonesia Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Pharmaceuticals Native Starch Market

• 17.1. South Korea Pharmaceuticals Native Starch Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Pharmaceuticals Native Starch Market

• 18.1. Taiwan Pharmaceuticals Native Starch Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Pharmaceuticals Native Starch Market

• 19.1. South East Asia Pharmaceuticals Native Starch Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Pharmaceuticals Native Starch Market

• 20.1. Western Europe Pharmaceuticals Native Starch Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Pharmaceuticals Native Starch Market

• 21.1. UK Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Pharmaceuticals Native Starch Market

• 22.1. Germany Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Pharmaceuticals Native Starch Market

• 23.1. France Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Pharmaceuticals Native Starch Market

• 24.1. Italy Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Pharmaceuticals Native Starch Market

• 25.1. Spain Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Pharmaceuticals Native Starch Market

• 26.1. Eastern Europe Pharmaceuticals Native Starch Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Pharmaceuticals Native Starch Market

• 27.1. Russia Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Pharmaceuticals Native Starch Market

• 28.1. North America Pharmaceuticals Native Starch Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Pharmaceuticals Native Starch Market

• 29.1. USA Pharmaceuticals Native Starch Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Pharmaceuticals Native Starch Market

• 30.1. Canada Pharmaceuticals Native Starch Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Pharmaceuticals Native Starch Market

• 31.1. South America Pharmaceuticals Native Starch Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Pharmaceuticals Native Starch Market

• 32.1. Brazil Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Pharmaceuticals Native Starch Market

• 33.1. Middle East Pharmaceuticals Native Starch Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Pharmaceuticals Native Starch Market

• 34.1. Africa Pharmaceuticals Native Starch Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Pharmaceuticals Native Starch Market Regulatory and Investment Landscape

36. Pharmaceuticals Native Starch Market Competitive Landscape And Company Profiles

• 36.1. Pharmaceuticals Native Starch Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Pharmaceuticals Native Starch Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Pharmaceuticals Native Starch Market Company Profiles
  • 36.3.1. Cargill Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Archer Daniels Midland Company Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Ingredion Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Roquette Freres SA Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Emsland Group Overview, Products and Services, Strategy and Financial Analysis

37. Pharmaceuticals Native Starch Market Other Major And Innovative Companies

• Tereos SCA, AGRANA Beteiligungs-AG, Grain Processing Corporation, Universal Starch-Chem Allied Ltd., SPAC Starch Products (India) Private Limited, Sanstar Biopolymers Ltd., Gulshan Polyols Ltd., Tate & Lyle Public Limited Company, BENEO GmbH, Hungrana Kft., Bluecraft Agro Pvt. Ltd., Visco Starch, Manildra Group, Shandong Liujia Pharmaceutical Excipient Co. Ltd., Zhucheng Xingmao Corn Developing Co. Ltd.

38. Global Pharmaceuticals Native Starch Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Pharmaceuticals Native Starch Market

40. Pharmaceuticals Native Starch Market High Potential Countries, Segments and Strategies

• 40.1 Pharmaceuticals Native Starch Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Pharmaceuticals Native Starch Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Pharmaceuticals Native Starch Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer